Cleber C. Melo‐Filho

1.2k total citations · 1 hit paper
29 papers, 726 citations indexed

About

Cleber C. Melo‐Filho is a scholar working on Computational Theory and Mathematics, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Cleber C. Melo‐Filho has authored 29 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Computational Theory and Mathematics, 10 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in Cleber C. Melo‐Filho's work include Computational Drug Discovery Methods (16 papers), Synthesis and biological activity (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Cleber C. Melo‐Filho is often cited by papers focused on Computational Drug Discovery Methods (16 papers), Synthesis and biological activity (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Cleber C. Melo‐Filho collaborates with scholars based in United States, Brazil and Ukraine. Cleber C. Melo‐Filho's co-authors include Carolina Horta Andrade, Rodolpho C. Braga, Eugene Muratov, Bruno J. Neves, José Teófilo Moreira‐Filho, Alexander Tropsha, Tesia Bobrowski, Vinícius M. Alves, Daniel Korn and Charles Schmitt and has published in prestigious journals such as Nature Communications, Environmental Health Perspectives and Journal of Medicinal Chemistry.

In The Last Decade

Cleber C. Melo‐Filho

23 papers receiving 715 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery

2018 295 citations Bruno J. Neves, Rodolpho C. Braga et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cleber C. Melo‐Filho United States	13	424	313	157	124	115	29	726
Thales Kronenberger Germany	16	244 0.6×	421 1.3×	152 1.0×	103 0.8×	68 0.6×	92	877
Osvaldo A. Santos‐Filho Brazil	18	232 0.5×	338 1.1×	368 2.3×	118 1.0×	170 1.5×	44	890
Jaime Pérez‐Villanueva Mexico	15	219 0.5×	250 0.8×	271 1.7×	44 0.4×	63 0.5×	36	638
José Teófilo Moreira‐Filho Brazil	9	350 0.8×	268 0.9×	124 0.8×	37 0.3×	49 0.4×	22	594
Paolo Coghi Macao	20	197 0.5×	382 1.2×	429 2.7×	111 0.9×	288 2.5×	75	1.2k
Marcelo S. Castilho Brazil	20	168 0.4×	431 1.4×	285 1.8×	60 0.5×	201 1.7×	64	840
Alessandro Schipani United Kingdom	14	244 0.6×	346 1.1×	201 1.3×	306 2.5×	68 0.6×	19	948
Maria Batool South Korea	13	326 0.8×	492 1.6×	104 0.7×	230 1.9×	40 0.3×	23	1.0k
Rafael Ferreira Dantas Brazil	15	154 0.4×	266 0.8×	198 1.3×	44 0.4×	76 0.7×	30	711
Rafael Gozalbes Spain	18	423 1.0×	381 1.2×	245 1.6×	40 0.3×	31 0.3×	49	827

Countries citing papers authored by Cleber C. Melo‐Filho

Since Specialization

Citations

This map shows the geographic impact of Cleber C. Melo‐Filho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cleber C. Melo‐Filho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cleber C. Melo‐Filho more than expected).

Fields of papers citing papers by Cleber C. Melo‐Filho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cleber C. Melo‐Filho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cleber C. Melo‐Filho. The network helps show where Cleber C. Melo‐Filho may publish in the future.

Co-authorship network of co-authors of Cleber C. Melo‐Filho

This figure shows the co-authorship network connecting the top 25 collaborators of Cleber C. Melo‐Filho. A scholar is included among the top collaborators of Cleber C. Melo‐Filho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cleber C. Melo‐Filho. Cleber C. Melo‐Filho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pourmousa, Mohsen, Sankalp Jain, Elena Barnaeva, et al.. (2025). AI-driven discovery of synergistic drug combinations against pancreatic cancer. Nature Communications. 16(1). 4020–4020. 6 indexed citations

Braga, Rodolpho C., Cleber C. Melo‐Filho, Maurício T. Tavares, et al.. (2025). Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment. Computers in Biology and Medicine. 197(Pt A). 110990–110990.

Melo‐Filho, Cleber C., José Teófilo Moreira‐Filho, Judy Strickland, et al.. (2025). External Validation of STopTox – Novel Alternative Method (NAM) for Acute Systemic and Topical Toxicity. Environmental Health Perspectives.

Melo‐Filho, Cleber C., et al.. (2025). On the importance of data curation for knowledge mining in antiviral research. Science Progress. 108(1). 342272031–342272031.

Melo‐Filho, Cleber C., et al.. (2024). Modeling interactions between Heparan sulfate and proteins based on the Heparan sulfate microarray analysis. Glycobiology. 34(7). 2 indexed citations

Melo‐Filho, Cleber C., Daniel Korn, Richard T. Eastman, et al.. (2023). Small molecule antiviral compound collection (SMACC): A comprehensive, highly curated database to support the discovery of broad-spectrum antiviral drug molecules. Antiviral Research. 217. 105620–105620. 7 indexed citations

Jain, Sankalp, Cleber C. Melo‐Filho, Tesia Bobrowski, et al.. (2022). Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 Agents. ACS Pharmacology & Translational Science. 5(7). 468–478. 11 indexed citations

Melo‐Filho, Cleber C., Tesia Bobrowski, Konstantin I. Popov, et al.. (2022). Conserved coronavirus proteins as targets of broad-spectrum antivirals. Antiviral Research. 204. 105360–105360. 23 indexed citations

Hou, Peiyu, Daniel Korn, Cleber C. Melo‐Filho, et al.. (2022). Compact Walks: Taming Knowledge-Graph Embeddings with Domain- and Task-Specific Pathways. Proceedings of the 2022 International Conference on Management of Data. 55. 458–469. 3 indexed citations

10.

Melo‐Filho, Cleber C., et al.. (2021). Explaining Drug-Discovery Hypotheses Using Knowledge-Graph Patterns. 2021 IEEE International Conference on Big Data (Big Data). 3709–3716. 3 indexed citations

11.

Bobrowski, Tesia, Cleber C. Melo‐Filho, Daniel Korn, et al.. (2020). Learning from history: do not flatten the curve of antiviral research!. Drug Discovery Today. 25(9). 1604–1613. 27 indexed citations

12.

Alves, Vinícius M., Tesia Bobrowski, Cleber C. Melo‐Filho, et al.. (2020). QSAR Modeling of SARS‐CoV M ^pro Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS‐CoV‐2. Molecular Informatics. 40(1). e2000113–e2000113. 63 indexed citations

13.

Neves, Bruno J., Rodolpho C. Braga, Cleber C. Melo‐Filho, et al.. (2018). QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery. Frontiers in Pharmacology. 9. 1275–1275. 295 indexed citations breakdown →

14.

Andrade, Carolina Horta, et al.. (2018). In Silico Chemogenomics Drug Repositioning Strategies for Neglected Tropical Diseases. Current Medicinal Chemistry. 26(23). 4355–4379. 19 indexed citations

15.

Melo‐Filho, Cleber C., Gustavo Capatti Cassiano, Bruno J. Neves, et al.. (2018). QSAR-Driven Design and Discovery of Novel Compounds With Antiplasmodial and Transmission Blocking Activities. Frontiers in Pharmacology. 9. 146–146. 19 indexed citations

16.

Melo‐Filho, Cleber C., Rodolpho C. Braga, Eugene Muratov, et al.. (2018). Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening. European Journal of Medicinal Chemistry. 163. 649–659. 22 indexed citations

17.

Mesquita, Juliana Tonini, Denise da Gama Jaén Batista, Cristiane França da Silva, et al.. (2018). Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study. The Journal of venomous animals and toxins including tropical diseases. 24(1). 30–30. 20 indexed citations

18.

Melo‐Filho, Cleber C., Rafael Ferreira Dantas, Rodolpho C. Braga, et al.. (2016). QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni. Journal of Chemical Information and Modeling. 56(7). 1357–1372. 41 indexed citations

19.

Melo‐Filho, Cleber C., Rodolpho C. Braga, & Carolina Horta Andrade. (2014). 3D-QSAR Approaches in Drug Design: Perspectives to Generate Reliable CoMFA Models. Current Computer - Aided Drug Design. 10(2). 148–159. 39 indexed citations

20.

Melo‐Filho, Cleber C., Rodolpho C. Braga, & Carolina Horta Andrade. (2014). Advances in Methods for Predicting Phase I Metabolism of Polyphenols. Current Drug Metabolism. 15(1). 120–126. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact